Samantha Semenkow
Stock Analyst at Citigroup
(0.67)
# 3,907
Out of 4,944 analysts
44
Total ratings
30.56%
Success rate
-22.82%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Samantha Semenkow
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WVE Wave Life Sciences | Initiates: Buy | $16 | $8.76 | +82.65% | 1 | Jul 16, 2025 | |
| PRME Prime Medicine | Downgrades: Neutral | $10 → $1.5 | $3.81 | -60.63% | 3 | May 27, 2025 | |
| CABA Cabaletta Bio | Maintains: Buy | $17 → $13 | $1.71 | +660.23% | 3 | May 16, 2025 | |
| ALLO Allogene Therapeutics | Maintains: Buy | $8 → $4 | $1.04 | +284.62% | 3 | May 15, 2025 | |
| ARGX argenx SE | Maintains: Buy | $796 → $803 | $646.60 | +24.19% | 6 | May 9, 2025 | |
| GPCR Structure Therapeutics | Initiates: Buy | $60 | $19.16 | +213.15% | 1 | May 2, 2025 | |
| BIOA BioAge Labs | Maintains: Neutral | $7 → $5 | $4.57 | +9.41% | 3 | Mar 24, 2025 | |
| VYGR Voyager Therapeutics | Initiates: Buy | $12 | $3.65 | +228.77% | 1 | Dec 2, 2024 | |
| CPRX Catalyst Pharmaceuticals | Maintains: Buy | $27 → $31 | $20.19 | +53.54% | 2 | Aug 9, 2024 | |
| SANA Sana Biotechnology | Maintains: Buy | $8 → $15 | $3.33 | +350.45% | 2 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $80 | $7.56 | +958.23% | 2 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $14 | $3.72 | +276.34% | 6 | May 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $15 | $3.08 | +387.01% | 4 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $72 | $55.65 | +29.38% | 1 | Dec 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $33 → $50 | $15.89 | +214.66% | 3 | Sep 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $56 | $17.52 | +219.63% | 3 | Aug 9, 2023 |
Wave Life Sciences
Jul 16, 2025
Initiates: Buy
Price Target: $16
Current: $8.76
Upside: +82.65%
Prime Medicine
May 27, 2025
Downgrades: Neutral
Price Target: $10 → $1.5
Current: $3.81
Upside: -60.63%
Cabaletta Bio
May 16, 2025
Maintains: Buy
Price Target: $17 → $13
Current: $1.71
Upside: +660.23%
Allogene Therapeutics
May 15, 2025
Maintains: Buy
Price Target: $8 → $4
Current: $1.04
Upside: +284.62%
argenx SE
May 9, 2025
Maintains: Buy
Price Target: $796 → $803
Current: $646.60
Upside: +24.19%
Structure Therapeutics
May 2, 2025
Initiates: Buy
Price Target: $60
Current: $19.16
Upside: +213.15%
BioAge Labs
Mar 24, 2025
Maintains: Neutral
Price Target: $7 → $5
Current: $4.57
Upside: +9.41%
Voyager Therapeutics
Dec 2, 2024
Initiates: Buy
Price Target: $12
Current: $3.65
Upside: +228.77%
Catalyst Pharmaceuticals
Aug 9, 2024
Maintains: Buy
Price Target: $27 → $31
Current: $20.19
Upside: +53.54%
Sana Biotechnology
Aug 9, 2024
Maintains: Buy
Price Target: $8 → $15
Current: $3.33
Upside: +350.45%
Jun 3, 2024
Reinstates: Buy
Price Target: $80
Current: $7.56
Upside: +958.23%
May 22, 2024
Maintains: Buy
Price Target: $10 → $14
Current: $3.72
Upside: +276.34%
May 9, 2024
Maintains: Buy
Price Target: $16 → $15
Current: $3.08
Upside: +387.01%
Dec 8, 2023
Initiates: Buy
Price Target: $72
Current: $55.65
Upside: +29.38%
Sep 27, 2023
Maintains: Buy
Price Target: $33 → $50
Current: $15.89
Upside: +214.66%
Aug 9, 2023
Maintains: Buy
Price Target: $60 → $56
Current: $17.52
Upside: +219.63%